In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner

被引:28
作者
Hume, SP
Brown, DJ
Ashworth, S
Hirani, E
Luthra, SK
Lammertsma, AA
机构
[1] PET Methodology Group, MRC Cyclotron Unit, Hammersmith Hospital, London W12 0NN, DuCane Road
[2] PET Centre, Free University Hospital, 1007 MB Amsterdam
关键词
positron emission tomography; rat; dopamine transporter; RTI-121; CFT;
D O I
10.1016/S0165-0270(97)00078-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
When estimated in vitro, the parameters which describe the binding of radiolabelled analogues of cocaine to sites on the dopamine transporter are very much influenced by the methodology used. In the present study, a small animal positron emission tomography (PET) scanner was used to estimate in vivo saturation kinetics for two carbon-11 labelled compounds presently used to monitor dopamine terminal function. The binding of [C-11]CFT (WIN 35,428) in rat striatum was adequately described by a single-site model, giving an apparent dissociation constant corresponding to an intravenous dose of 242 nmol/kg. In contrast, the binding of [C-11]RTI-121 was better described by a two-site model with the 'high-affinity' site or state (dissociation constant = 1 nmol/kg) being significantly occupied at doses routinely used in PET scanning. Such findings cannot readily be predicted from in vitro work, but could aid in both the choice of ligand and the model used in quantification of scan data. While multi-dose in vivo PET studies are difficult in man, rat PET can easily be employed either pre-clinically for putative radioligands, or experimentally, to study drug interactions and receptor occupancy related to functional efficacy. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 32 条
[1]  
ALOYO VJ, 1995, J PHARMACOL EXP THER, V273, P435
[2]   REGIONAL BRAIN UPTAKE AND PHARMACOKINETICS OF [I-123] N-OMEGA-FLUOROALKYL-2-BETA-CARBOXY-3-BETA-(4-IODOPHENYL)NORTROPANE ESTERS IN BABOONS [J].
BALDWIN, RM ;
ZEAPONCE, Y ;
ALTIKRITI, MS ;
ZOGHBI, SS ;
SEIBYL, JP ;
CHARNEY, DS ;
HOFFER, PB ;
WANG, SY ;
MILIUS, RA ;
NEUMEYER, JL ;
INNIS, RB .
NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (02) :211-219
[3]   THE DESIGN AND PHYSICAL CHARACTERISTICS OF A SMALL ANIMAL POSITRON EMISSION TOMOGRAPH [J].
BLOOMFIELD, PM ;
RAJESWARAN, S ;
SPINKS, TJ ;
HUME, SP ;
MYERS, R ;
ASHWORTH, S ;
CLIFFORD, KM ;
JONES, WF ;
BYARS, LG ;
YOUNG, J ;
ANDREACO, M ;
WILLIAMS, CW ;
LAMMERTSMA, AA ;
JONES, T .
PHYSICS IN MEDICINE AND BIOLOGY, 1995, 40 (06) :1105-1126
[4]  
BOJA JW, 1995, MOL PHARMACOL, V47, P779
[5]   SELECTIVE DOPAMINE TRANSPORTER INHIBITION BY COCAINE ANALOGS [J].
BOJA, JW ;
MCNEILL, RM ;
LEWIN, AH ;
ABRAHAM, P ;
CARROLL, FI ;
KUHAR, MJ .
NEUROREPORT, 1992, 3 (11) :984-986
[6]  
Brown D. J., 1994, Journal of Labelled Compounds and Radiopharmaceuticals, V35, P483
[7]  
BROWN DJ, 1997, IN PRESS J LABELLED
[8]   SYNTHESIS OF A RADIOTRACER FOR STUDYING DOPAMINE UPTAKE SITES INVIVO USING PET - 2-BETA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)-[N-C-11-METHYL]TROPANE ([C-11]CFT OR [C-11] WIN-35,428) [J].
DANNALS, RF ;
NEUMEYER, JL ;
MILIUS, RA ;
RAVERT, HT ;
WILSON, AA ;
WAGNER, HN .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1993, 33 (02) :147-152
[9]  
DMELLO GD, 1981, J PHARMACOL EXP THER, V219, P60
[10]   PET STUDY OF [C-11] BETA-CIT BINDING TO MONOAMINE TRANSPORTERS IN THE MONKEY AND HUMAN BRAIN [J].
FARDE, L ;
HALLDIN, C ;
MULLER, L ;
SUHARA, T ;
KARLSSON, P ;
HALL, H .
SYNAPSE, 1994, 16 (02) :93-103